Scholarlink

Purpose <p>Diagnosing extrapulmonary tuberculosis (EPTB) – including pleural, peritoneal, pericardial, meningeal forms – remains challenging due to the insufficient sensitivity of smear microscopy (SM), mycobacteriological culture, and nucleic acid amplification test (NAAT). The Adenosine Deaminase (ADA) assay has potential as a diagnostic tool for EPTB, but its performance in high-income countries is poorly documented. This study aimed to evaluate the diagnostic performance of ADA for microbiologically confirmed EPTB in such a setting.</p> Methods <p>We retrospectively analyzed data from all patients undergoing ADA testing in our hospital network in Paris area between May 2014 and April 2024. Microbiological confirmation (positive SM, culture, or NAAT) from the same sample site served as the reference standard.</p> Results <p>Among 363 ADA assays (352 patients), 69% were pleural fluid, 18% peritoneal, &lt; 1% pericardial, 11% CSF. For pleural fluid, ADA at a threshold of 30 U/L demonstrated 92% sensitivity (CI 80–98%), 75% specificity (CI 68–81%), 47% PPV (CI 37–57%), and 97% NPV (CI 94–99%). For peritoneal fluid, sensitivity, specificity, PPV, and NPV were 77% (CI 46–95%), 81% (CI 69–91%), 50% (CI 27–73%), and 94% (CI 82–99%), respectively. Raising the ADA threshold to 60 U/L improved specificity to 92% in pleural fluid (CI 87–95%) and 85% in peritoneal fluid (CI 73–93%). Combining ADA with other biomarkers showed no added diagnostic value.</p> Conclusion <p>ADA testing is a rapid and practical tool for EPTB diagnosis. In pleural and peritoneal fluids, a threshold &lt; 30 U/L effectively excludes EPTB, while a threshold &gt; 60 U/L supports initiating treatment pending culture results.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnostic performance of adenosine deaminase for extrapulmonary tuberculosis in a higher-prevalence area of mainland France: a 10-year retrospective study

  • 期刊论文

  • 发表日期：

    2025年8月8日

查看全文
  • Quiterie Boscals de Réals,
  • Ugo Françoise,
  • Nicolas Vignier,
  • Hervé Delacour,
  • Frédéric Méchaï

摘要

Purpose

Diagnosing extrapulmonary tuberculosis (EPTB) – including pleural, peritoneal, pericardial, meningeal forms – remains challenging due to the insufficient sensitivity of smear microscopy (SM), mycobacteriological culture, and nucleic acid amplification test (NAAT). The Adenosine Deaminase (ADA) assay has potential as a diagnostic tool for EPTB, but its performance in high-income countries is poorly documented. This study aimed to evaluate the diagnostic performance of ADA for microbiologically confirmed EPTB in such a setting.

Methods

We retrospectively analyzed data from all patients undergoing ADA testing in our hospital network in Paris area between May 2014 and April 2024. Microbiological confirmation (positive SM, culture, or NAAT) from the same sample site served as the reference standard.

Results

Among 363 ADA assays (352 patients), 69% were pleural fluid, 18% peritoneal, < 1% pericardial, 11% CSF. For pleural fluid, ADA at a threshold of 30 U/L demonstrated 92% sensitivity (CI 80–98%), 75% specificity (CI 68–81%), 47% PPV (CI 37–57%), and 97% NPV (CI 94–99%). For peritoneal fluid, sensitivity, specificity, PPV, and NPV were 77% (CI 46–95%), 81% (CI 69–91%), 50% (CI 27–73%), and 94% (CI 82–99%), respectively. Raising the ADA threshold to 60 U/L improved specificity to 92% in pleural fluid (CI 87–95%) and 85% in peritoneal fluid (CI 73–93%). Combining ADA with other biomarkers showed no added diagnostic value.

Conclusion

ADA testing is a rapid and practical tool for EPTB diagnosis. In pleural and peritoneal fluids, a threshold < 30 U/L effectively excludes EPTB, while a threshold > 60 U/L supports initiating treatment pending culture results.